ProfileGDS4132 / 220764_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 38% 41% 42% 37% 30% 33% 33% 37% 38% 31% 45% 39% 38% 60% 39% 44% 44% 53% 41% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10198.080738
GSM201543Muscle PCOS pioglitazone 12197.043241
GSM201544Muscle PCOS pioglitazone 161112.40942
GSM201545Muscle PCOS pioglitazone 201103.72637
GSM201829Muscle PCOS pioglitazone 23179.666130
GSM201830Muscle PCOS pioglitazon 25183.926333
GSM201831Muscle PCOS pioglitazone 27179.866133
GSM201832Muscle PCOS pioglitazone 3193.789437
GSM201833Muscle PCOS pioglitazone 4192.299738
GSM201834Muscle PCOS pioglitazone 8173.386431
GSM201835Muscle PCOS after pioglitazone 102103.12645
GSM201836Muscle PCOS after pioglitazone 12289.623939
GSM201837Muscle PCOS after pioglitazone 16282.409338
GSM201838Muscle PCOS after pioglitazone 202158.84960
GSM201839Muscle PCOS after pioglitazone 23294.083639
GSM201840Muscle PCOS after pioglitazone 252110.97244
GSM201841Muscle PCOS after pioglitazone 27299.149844
GSM201842Muscle PCOS after pioglitazone 32121.79853
GSM201843Muscle PCOS after pioglitazone 42103.38341
GSM201844Muscle PCOS after pioglitazone 82103.2142